These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3464277)

  • 21. Solubilization and characterization of prostaglandin E2 binding protein from porcine cerebral cortex.
    Yumoto N; Watanabe Y; Watanabe K; Watanabe Y; Hayaishi O
    J Neurochem; 1986 Jan; 46(1):125-32. PubMed ID: 3455668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of radioactivity of tritiated prostaglandins E2 and A2 in rat tissues including a renal autoradiographic study.
    Pellegrin MJ; Astoin M
    Arch Int Physiol Biochim; 1976 Apr; 84(2):285-92. PubMed ID: 71032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability.
    Granström E; Hamberg M; Hansson G; Kindahl H
    Prostaglandins; 1980 Jun; 19(6):933-57. PubMed ID: 7384561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60.
    Ishioka C; Kanamaru R; Sato T; Dei T; Konishi Y; Asamura M; Wakui A
    Cancer Res; 1988 May; 48(10):2813-8. PubMed ID: 3162825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
    Ohno K; Sakai T; Fukushima M; Narumiya S; Fujiwara M
    J Pharmacol Exp Ther; 1988 Apr; 245(1):294-8. PubMed ID: 3361448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
    Fischer A; Le Deist F; Durandy A; Griscelli C
    J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cyclopentenone prostaglandin PGA2 costimulates the maturation of human dendritic cells.
    Thurnher M; Putz T; Gander H; Rahm A; Bartsch G; Ramoner R
    Exp Hematol; 2005 Feb; 33(2):144-50. PubMed ID: 15676206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that a short-lived effect of copper leads to amplification of prostaglandin E2 stimulation of the release of gonadotropin-releasing hormone from median eminence explants.
    Barnea A; Cho G; Colombani-Vidal M
    Endocrinology; 1986 Sep; 119(3):1254-61. PubMed ID: 3525128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of growth in oral squamous carcinoma cells by cyclopentenone prostaglandins: comparison with chemotherapeutic agents.
    ElAttar TM; Virji AS
    Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):461-5. PubMed ID: 9223658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
    Rocklin RE; Thistle L; Audera C
    J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astrocytes synthesize primary and cyclopentenone prostaglandins that are negative regulators of their proliferation.
    Chistyakov DV; Grabeklis S; Goriainov SV; Chistyakov VV; Sergeeva MG; Reiser G
    Biochem Biophys Res Commun; 2018 Jun; 500(2):204-210. PubMed ID: 29634926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC; Schollmeyer P
    Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of CFU-f formation by prostaglandin E2 is mediated in part by its degradation product, prostaglandin A2.
    Still K; Scutt A
    Prostaglandins Other Lipid Mediat; 2001 May; 65(1):21-31. PubMed ID: 11352224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
    Mahan M; Meunier J; Newby M; Young MR
    J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
    Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
    Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
    Robin JL; Seldin DC; Austen KF; Lewis RA
    J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo modulation of myelopoiesis by prostaglandin E2. IV. Prostaglandin E2 induction of myelopoietic inhibitory activity.
    Gentile PS; Pelus LM
    J Immunol; 1988 Oct; 141(8):2714-20. PubMed ID: 3171182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous determination of prostaglandins (PG) E2, A2 and B2 and stability studies of PGE2 in pharmaceutical preparations by ion-pair reversed phase HPLC.
    Amin M
    Pharm Acta Helv; 1989; 64(2):45-50. PubMed ID: 2717650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins.
    Abdel-Malek ZA; Swope VB; Amornsiripanitch N; Nordlund JJ
    Cancer Res; 1987 Jun; 47(12):3141-6. PubMed ID: 2438034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.
    Khan SH; Sorof S
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9401-5. PubMed ID: 2251282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.